Cost-utility analysis of memantine in Alzheimer’s disease in Brazil

Oliveira, I.A.G.D. orcid.org/0000-0002-4920-4843, Caetano, R. orcid.org/0000-0003-1480-2453, Steffen, R.E. orcid.org/0000-0002-9733-5098 et al. (1 more author) (2022) Cost-utility analysis of memantine in Alzheimer’s disease in Brazil. Research, Society and Development, 11 (11). e556111133846. ISSN 2525-3409

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2022 Ione Ayala Gualandi de Oliveira; Rosângela Caetano; Ricardo Ewback Steffen; Aline Navega Biz. This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).

Keywords: Alzheimer’s disease; Cost-utility analysis; Memantine; Unified health system
Dates:
  • Published: 8 December 2022
  • Published (online): 2 September 2022
  • Accepted: 25 August 2022
  • Submitted: 8 August 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 09 Jan 2025 14:58
Last Modified: 09 Jan 2025 14:58
Status: Published
Publisher: Research, Society and Development
Refereed: Yes
Identification Number: 10.33448/rsd-v11i11.33846
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Export

Statistics